Back to the Top
The following message was posted to: PharmPK
Does anyone have references or other documentation of pharmaceutical
companies going back to cull more information about their drug from
prior studies (retrospective analysis). For example, a drug may have
been developed to lower LDL cholesterol, and the company may have
gone back to the clinical study data to see if longevity was enhanced
-- or another example, in a PK study on a SR product, a retrospective
analysis was conducted to re-evaluate adverse events. Anecdotal
comments would also be welcomed. Thanks.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Retrospective Study Analysis" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)